Stock Fundamentals

Company Information

▼
Company Name
Fate Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US31189P1021
CIK: 0001434316
CUSIP: 31189P102
Currency: USD
Full Time Employees: 161
Phone: 858 875 1800
Website: https://www.fatetherapeutics.com
Fiscal Year End: December
IPO Date: Oct 01, 2013
Description:

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT836 which is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, FT839, to treat complex autoimmune diseases; and FT825 to treat solid tumors. It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. The company was incorporated in 2007 and is headquartered in San Diego, California.

Address:

12278 Scripps Summit Drive, San Diego, CA, United States, 92131

Directors & Officers

▼
Name Title Year Born
Dr. Bahram Valamehr M.B.A., Ph.D. President, CEO & Director 1977
Ms. Cindy R. Tahl J.D. Chief Legal & Compliance Officer and Corporate Secretary 1973
Mr. Kamal Adawi M.S., MBA Chief Financial Officer 1979

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
Redmile Group, LLC 12.87M Sep 30, 2025 11.07% $1.58 0.00%
BlackRock Inc 10.68M Sep 30, 2025 9.19% $0.00 -1.20%
Vanguard Group Inc 8.97M Dec 31, 2025 7.72% $0.00 1.96%
Wilshire Advisors 8.49M Sep 30, 2025 7.30% $27.71 0.00%
Johnson & Johnson 3.38M Sep 30, 2025 2.91% $0.85 0.00%
Acadian Asset Management LLC 2.71M Sep 30, 2025 2.33% $0.01 16,264.17%
Geode Capital Management, LLC 2.53M Sep 30, 2025 2.18% $0.00 4.16%
State Street Corp 2.42M Sep 30, 2025 2.08% $0.00 8.43%
Renaissance Technologies Corp 2.36M Dec 31, 2025 2.03% $0.00 87.00%
TANG CAPITAL MANAGEMENT LLC 1.87M Sep 30, 2025 1.61% $0.09 0.00%
Two Sigma Investments LLC 1.73M Dec 31, 2025 1.49% $0.00 92.51%
Vestal Point Capital LP 1.73M Dec 31, 2025 1.48% $0.06 -31.41%
Two Sigma Advisers, LLC 1.65M Dec 31, 2025 1.42% $0.00 63.96%
Dimensional Fund Advisors, Inc. 1.58M Dec 31, 2025 1.36% $0.00 -24.70%
The Goldman Sachs Group Inc 1.49M Sep 30, 2025 1.28% $0.00 -40.82%
AQR Capital Management LLC 1.13M Sep 30, 2025 0.97% $0.00 33.70%
Millennium Management LLC 963.87K Sep 30, 2025 0.83% $0.00 9.57%
Morgan Stanley - Brokerage Accounts 929.94K Sep 30, 2025 0.80% $0.00 -61.79%
Citadel Advisors Llc 824.55K Sep 30, 2025 0.71% $0.00 -81.85%
Northern Trust Corp 814.47K Sep 30, 2025 0.70% $0.00 -3.54%

Shares Statistics

▼
Shares Outstanding: 116.26M
Shares Float: 101.62M
% Insiders: 188.90%
% Institutions: 7,857.90%
Short % Float: 9.37%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 Redmile Group, LLC 12.87M 11.07% ▲ 0.00% Sep 30, 2025
2 BlackRock Inc 10.68M 9.19% ▼ 1.20% Sep 30, 2025
3 Vanguard Group Inc 8.97M 7.72% ▲ 1.96% Dec 31, 2025
4 Wilshire Advisors 8.49M 7.30% ▲ 0.00% Sep 30, 2025
5 Johnson & Johnson 3.38M 2.91% ▲ 0.00% Sep 30, 2025
6 Acadian Asset Management LLC 2.71M 2.33% ▲ 16,264.17% Sep 30, 2025
7 Geode Capital Management, LLC 2.53M 2.18% ▲ 4.16% Sep 30, 2025
8 State Street Corp 2.42M 2.08% ▲ 8.43% Sep 30, 2025
9 Renaissance Technologies Corp 2.36M 2.03% ▲ 87.00% Dec 31, 2025
10 TANG CAPITAL MANAGEMENT LLC 1.87M 1.61% ▲ 0.00% Sep 30, 2025

Valuation Metrics

▼
Enterprise Value: $10.22M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $136.03M
EBITDA: $-133.70M
PEG Ratio: $0.00
Book Value: $1.80
Earnings/Share: $-1.15
Profit Margin: 0.00%
Operating Margin: -2,455.88%
ROA (TTM): -24.12%
ROE (TTM): -51.84%
Revenue (TTM): $6.65M
Revenue/Share (TTM): $0.06
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -26.40%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 5.79x 0.02x 0.35x N/A -0.04x
2024-12-31 7.58x 0.02x 0.28x N/A -0.04x
2023-12-31 8.48x 0.02x 0.27x N/A -0.04x
2022-12-31 4.40x 0.01x 0.31x -52.79x -0.02x
2021-12-31 7.79x 0.01x 0.26x -47.79x -0.03x
2020-12-31 5.78x 0.01x 0.38x -53.37x -0.03x
2019-12-31 8.17x 0.01x 0.19x -57.49x -0.02x
2018-12-31 7.53x 0.09x 0.25x -39.56x -0.23x
2017-12-31 9.29x 0.29x 0.27x -33.22x -0.54x
2016-12-31 6.14x 0.15x 0.23x -19.53x -0.35x
2015-12-31 4.88x 0.45x 0.44x -12.51x -0.64x
2014-12-31 10.89x 0.69x 0.45x -45.36x -0.80x
2013-12-31 11.88x 0.03x 0.09x -22.20x -0.09x
2012-12-31 2.02x -0.07x 5.77x -27.84x -0.28x
2011-12-31 1.82x -0.10x 7.45x -104.67x -0.38x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jan 09, 2026 Bahram Valamehr N/A Sale 5.19K $1.07 $5.55K
Jan 09, 2026 Cindy Tahl N/A Sale 10.59K $1.06 $11.22K
Aug 04, 2025 Bahram Valamehr N/A Sale 14.47K $1.06 $15.33K
Aug 04, 2025 Cindy Tahl N/A Sale 9.04K $1.06 $9.58K

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about FATE.US!